Phenotypic Clustering of Beta-Thalassemia Intermedia Patients Using Cardiovascular Magnetic Resonance
- PMID: 37959172
- PMCID: PMC10647397
- DOI: 10.3390/jcm12216706
Phenotypic Clustering of Beta-Thalassemia Intermedia Patients Using Cardiovascular Magnetic Resonance
Abstract
We employed an unsupervised clustering method that integrated demographic, clinical, and cardiac magnetic resonance (CMR) data to identify distinct phenogroups (PGs) of patients with beta-thalassemia intermedia (β-TI). We considered 138 β-TI patients consecutively enrolled in the Myocardial Iron Overload in Thalassemia (MIOT) Network who underwent MR for the quantification of hepatic and cardiac iron overload (T2* technique), the assessment of biventricular size and function and atrial dimensions (cine images), and the detection of replacement myocardial fibrosis (late gadolinium enhancement technique). Three mutually exclusive phenogroups were identified based on unsupervised hierarchical clustering of principal components: PG1, women; PG2, patients with replacement myocardial fibrosis, increased biventricular volumes and masses, and lower left ventricular ejection fraction; and PG3, men without replacement myocardial fibrosis, but with increased biventricular volumes and masses and lower left ventricular ejection fraction. The hematochemical parameters and the hepatic and cardiac iron levels did not contribute to the PG definition. PG2 exhibited a significantly higher risk of future cardiovascular events (heart failure, arrhythmias, and pulmonary hypertension) than PG1 (hazard ratio-HR = 10.5; p = 0.027) and PG3 (HR = 9.0; p = 0.038). Clustering emerged as a useful tool for risk stratification in TI, enabling the identification of three phenogroups with distinct clinical and prognostic characteristics.
Keywords: cardiovascular magnetic resonance imaging; clustering; phenomapping; thalassemia intermedia.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network.Radiol Med. 2024 Jun;129(6):879-889. doi: 10.1007/s11547-024-01821-y. Epub 2024 Apr 29. Radiol Med. 2024. PMID: 38683500
-
Phenotypic Clustering of Patients With Newly Diagnosed Coronary Artery Disease Using Cardiovascular Magnetic Resonance and Coronary Computed Tomography Angiography.Front Cardiovasc Med. 2021 Nov 18;8:760120. doi: 10.3389/fcvm.2021.760120. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34869675 Free PMC article.
-
Prognostic value of multiparametric cardiac magnetic resonance in sickle cell patients.Ann Hematol. 2023 Feb;102(2):261-270. doi: 10.1007/s00277-022-05057-6. Epub 2022 Dec 2. Ann Hematol. 2023. PMID: 36459182
-
Magnetic Resonance Evaluation of Tissue Iron Deposition and Cardiac Function in Adult Regularly Transfused Thalassemia Intermedia Compared with Thalassemia Major Patients.J Clin Med. 2024 Aug 14;13(16):4791. doi: 10.3390/jcm13164791. J Clin Med. 2024. PMID: 39200932 Free PMC article.
-
Heart failure in beta-thalassemia syndromes: a decade of progress.Am J Med. 2005 Sep;118(9):957-67. doi: 10.1016/j.amjmed.2005.02.021. Am J Med. 2005. PMID: 16164878 Review.
Cited by
-
Autologous cell therapy for ischemic diabetic foot: a meta-analysis of randomized controlled trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome.Acta Diabetol. 2025 May;62(5):743-752. doi: 10.1007/s00592-024-02393-z. Epub 2024 Nov 15. Acta Diabetol. 2025. PMID: 39545964
References
Grants and funding
LinkOut - more resources
Full Text Sources